title: Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells.
abstract: Glioblastoma multiforme is the most undifferentiated type of brain tumor, and its prognosis is extremely poor. Glioblastoma cells exhibit highly migratory and invasive behavior, which makes surgical intervention unsuccessful. Here, we showed that glioblastoma cells express Ca(2+)-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA)-type glutamate receptors assembled from the GluR1 and/or GluR4 subunits, and that their conversion to Ca(2+)-impermeable receptors by adenovirus-mediated transfer of the GluR2 cDNA inhibited cell locomotion and induced apoptosis. In contrast, overexpression of Ca(2+)-permeable AMPA receptors facilitated migration and proliferation of the tumor cells. These findings indicate that Ca(2+)-permeable AMPA receptors have crucial roles in growth of glioblastoma. Blockage of these Ca(2+)-permeable receptors may be a useful therapeutic strategy for the prevention of glioblastoma invasion.
authors.affiliation: Department of Neurosurgery, Gunma University School of Medicine, Maebashi, Gunma, Japan. ishogo@showa.gunma-u.ac.jp
authors.forename: Shogo
authors.initials: S
authors.lastname: Ishiuchi
authors.forename: Keisuke
authors.initials: K
authors.lastname: Tsuzuki
authors.forename: Yukari
authors.initials: Y
authors.lastname: Yoshida
authors.forename: Nobuaki
authors.initials: N
authors.lastname: Yamada
authors.forename: Norikazu
authors.initials: N
authors.lastname: Hagimura
authors.forename: Haruo
authors.initials: H
authors.lastname: Okado
authors.forename: Akiko
authors.initials: A
authors.lastname: Miwa
authors.forename: Hideyuki
authors.initials: H
authors.lastname: Kurihara
authors.forename: Yoichi
authors.initials: Y
authors.lastname: Nakazato
authors.forename: Masaru
authors.initials: M
authors.lastname: Tamura
authors.forename: Tomio
authors.initials: T
authors.lastname: Sasaki
authors.forename: Seiji
authors.initials: S
authors.lastname: Ozawa
mesh_terms: D000256:Adenoviridae / Q000235:genetics; D000818:Animals; D017209:Apoptosis; D001932:Brain Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology*; D002118:Calcium / Q000378:metabolism; D002465:Cell Movement / Q000235:genetics; D005822:Genetic Vectors / Q000494:pharmacology; D005909:Glioblastoma / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D051379:Mice; D008819:Mice, Nude; D010539:Permeability; D011810:Quinoxalines / Q000494:pharmacology; D018091:Receptors, AMPA / Q000037:antagonists & inhibitors* / Q000187:drug effects / Q000235:genetics / Q000378:metabolism; D014407:Tumor Cells, Cultured; D018350:alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid / Q000378:metabolism / Q000494:pharmacology
chemical_list: D002118:Calcium; D007093:Imidazoles; D011810:Quinoxalines; D018091:Receptors, AMPA; D018350:alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; C104724:glutamate receptor ionotropic, AMPA 4; C062865:2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline; C110629:YM 872; C104722:glutamate receptor ionotropic, AMPA 2